27th Annual Meeting of the European Society for Pediatric Infectious Disease

作者: Ener Cagri Dinleyici , Zeynel Abidin Yargic

DOI: 10.1586/ERV.09.75

关键词:

摘要: The 27th Annual Meeting of the European Society for Pediatric Infectious Disease (ESPID) was held in Brussels, Belgium, on 8-13 June 2009. Europe's largest pediatric infectious disease congress brought international pediatricians and experts vaccine together. Owing to numerous topics issues that were discussed, this report we summarize current knowledge about pneumococcal conjugate vaccines (PCVs). main covered are seroepidemiology after introduction 7-valent conjugated (PCV7), efficacy immunogenicity a reduced-dose schedule PCV7, effectiveness PCV7 against invasive disease, otitis media related conditions, pneumonia, nasopharyngeal carriage. New studies, including cost-effectiveness currently licensed 10-valent vaccine, which uses protein D from nontypeable Haemophilus influenzae (PHiD-CV) investigational PCVs (investigational 13-valent PCV [PCV13] 11-valent [PCV11]), also presented. Next year, 28th ESPID meeting will be Nice, France, 4-8 2010. We have chance see evaluate, PHiD-CV era, studies new vaccines. With 2015 key millennium development goalonly 5 years away, need accelerate evaluate newcomer order reduce mortality rate among children younger than age by two-thirds.

参考文章(34)
Philippe De Wals, Michel Carbon, Elodie Sévin, Geneviève Deceuninck, Manale Ouakki, Reduced physician claims for otitis media after implementation of pneumococcal conjugate vaccine program in the province of Quebec, Canada. Pediatric Infectious Disease Journal. ,vol. 28, ,(2009) , 10.1097/INF.0B013E3181BAD212
Simon Rückinger, Mark van der Linden, Ralf René Reinert, Rüdiger von Kries, Florian Burckhardt, Anette Siedler, Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. Vaccine. ,vol. 27, pp. 4136- 4141 ,(2009) , 10.1016/J.VACCINE.2009.04.057
Aaron E. Chen, Joseph B. Cantey, Karen C. Carroll, Tracy Ross, Sharon Speser, George K. Siberry, Discordance between Staphylococcus aureus nasal colonization and skin infections in children. Pediatric Infectious Disease Journal. ,vol. 28, pp. 244- 246 ,(2009) , 10.1097/INF.0B013E31818CB0C4
Ener Cagri Dinleyici, Zeynel Abidin Yargic, Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine. Expert Review of Vaccines. ,vol. 8, pp. 977- 986 ,(2009) , 10.1586/ERV.09.68
Robert I. Menzies, Shelley L. Deeks, Mahomed S. Patel, Peter B. McIntyre, Andrew Jardine, The impact of pneumococcal conjugate vaccine on rates of myringotomy with ventilation tube insertion in Australia. Pediatric Infectious Disease Journal. ,vol. 28, pp. 761- 765 ,(2009) , 10.1097/INF.0B013E31819E9BC5
Keith P. Klugman, Christina Mills Astley, Marc Lipsitch, Time from illness onset to death, 1918 influenza and pneumococcal pneumonia. Emerging Infectious Diseases. ,vol. 15, pp. 346- 347 ,(2009) , 10.3201/EID1502.081208
Juan Casado-Flores, Carlos Rodrigo, Javier Arístegui, Jose María Martínón, Asunción Fenoll, Cristina Mendez, Decline in pneumococcal meningitis in Spain after introduction of the heptavalent pneumococcal conjugate vaccine. Pediatric Infectious Disease Journal. ,vol. 27, pp. 1020- 1022 ,(2008) , 10.1097/INF.0B013E31817BD2DC
F Dubos, I Marechal, M O Husson, C Courouble, M Aurel, A Martinot, , Decline in pneumococcal meningitis after the introduction of the heptavalent-pneumococcal conjugate vaccine in northern France Archives of Disease in Childhood. ,vol. 92, pp. 1009- 1012 ,(2007) , 10.1136/ADC.2007.119891
Andrew Riordan, Ali Judd, Katherine Boyd, David Cliff, Katia Doerholt, Hermione Lyall, Esse Menson, Karina Butler, Di Gibb, Tenofovir use in human immunodeficiency virus-1-infected children in the United kingdom and Ireland. Pediatric Infectious Disease Journal. ,vol. 28, pp. 204- 209 ,(2009) , 10.1097/INF.0B013E31818C8D2C
Stephen I. Pelton, Eugene Leibovitz, Recent advances in otitis media. Pediatric Infectious Disease Journal. ,vol. 28, ,(2009) , 10.1097/INF.0B013E3181B6D81A